Micronodular Thymic Carcinoma With Lymphoid Hyperplasia: A Case Report and Next Generation Sequencing Analysis With its Benign Counterpart Multinodular Thymoma With Lymphoid Stroma
- 22 July 2025
- journal article
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (1) , 207-215
Abstract
Micronodular thymic carcinoma with lymphoid hyperplasia (MNC) is an extremely rare tumor. Fewer than 30 histologically proven examples of MNC have been described in the English literature. A 64-year-old man with a history of colon cancer presented with an anterior mediastinal mass on follow-up examination. Surgical excision was performed. Macroscopically, the mass (3.0 × 2.7 cm) was relatively well-demarcated and surrounded by fat. The cut surface was tan yellow and solid. Microscopically, it showed multiple small tumor islands composed of frankly malignant epithelial cells with pleomorphism and increased mitotic activity. They were arranged in a micronodular growth pattern and surrounded by lymphoid stroma composed of CD3-positive small T-lymphocytes and CD20-positive B-lymphocytes, highlighting numerous lymphoid follicles with germinal centers. A diagnosis of MNC was made. We also report comparatively analyzed genetic alterations in MNC and its benign counterpart, micronodular thymoma with lymphoid stroma (MNT) by next-generation sequencing. For therapeutic interventions, awareness of this rare disease is essential in order not to confuse this tumor with MNT or metastatic carcinoma in mediastinal lymph nodes. And further clinical concordance studies with genomic analysis in the larger number of MNCs should be followed.Keywords
This publication has 30 references indexed in Scilit:
- The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?Journal of Thoracic Oncology, 2022
- Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis—a RYTHMIC studyVirchows Archiv, 2021
- Erratum to “High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors” [Lung Cancer 132 (June) (2019) 9–16]Lung Cancer, 2019
- USP9X stabilizes BRCA1 and confers resistance to DNA‐damaging agents in human cancer cellsCancer Medicine, 2019
- Functional Interaction of BRCA1 and CREBBP in Murine HematopoiesisiScience, 2019
- The Integrated Genomic Landscape of Thymic Epithelial TumorsCancer Cell, 2018
- Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic TargetsPathology and Oncology Research, 2016
- Micronodular thymic carcinoma with lymphoid hyperplasia: a clinicopathological and immunohistochemical study of five casesLaboratory Investigation, 2012
- Steroid receptor expression in thymomas and thymic carcinomasCancer, 2011
- Chromosome 6 Suffers Frequent and Multiple Aberrations in ThymomaThe American Journal of Pathology, 2002